Abstract:ASPP2 and iASPP bind to p53 through their conserved ANK-SH3 domains to respectively promote and inhibit p53-dependent cell apoptosis. While crystallography has indicated that these two proteins employ distinct surfaces of their ANK-SH3 domains to bind to p53, solution NMR data has suggested similar surfaces. In this study, we employed multi-scale molecular dynamics (MD) simulations combined with free energy calculations to reconcile the discrepancy in the binding modes. We demonstrated that the binding mode based solely on a single crystal structure does not enable iASPP's RT loop to engage with p53's C-terminal linker—a verified interaction. Instead, an ensemble of simulated iASPP-p53 complexes facilitates this interaction. We showed that the ensemble-average inter-protein contacting residues and NMR-detected interfacial residues qualitatively overlap on ASPP proteins, and the ensemble-average binding free energies better match experimental K D values compared to single crystallgarphy-determined binding mode. For iASPP, the sampled ensemble complexes can be grouped into two classes, resembling the binding modes determined by crystallography and solution NMR. We thus propose that crystal packing shifts the equilibrium of binding modes towards the crystallography-determined one. Lastly, we showed that the ensemble binding complexes are sensitive to p53's intrinsically disordered regions (IDRs), attesting to experimental observations that these IDRs contribute to biological functions. Our results provide a dynamic and ensemble perspective for scrutinizing these important cancer-related protein-protein interactions (PPIs). Solution NMR and crystallography often yield disparate results when determining the biologically relevant binding modes of protein-protein interactions. Through computational modeling, we successfully reconciled the discrepancies in binding modes reported by NMR and crystallography for the tumor suppressor protein p53 and its regulators, ASPP2, and iASPP. We demonstrated that the controversial binding modes determined by NMR and crystallography for iASPP-p53 are, in fact, the two major binding modes captured in free protein-protein binding simulations. Therefore, both reported binding modes are plausible, and crystal packing influences the preference for the mode captured in crystallography. Our results underscore the concept that proteins function through dynamic ensembles, and under physiological conditions, protein-protein interactions can have more than one binding mode. Using this ensemble binding framework, we explore the roles of disordered regions of p53 in complex formation, demonstrating how the overlooked IDRs can fine-tune protein-protein interactions.

Impact of Nonnative Interactions on the Binding Kinetics of Intrinsically Disordered P53 with MDM2: Insights from All-Atom Simulation and Markov State Model Analysis.

Free Energy Profile and Kinetics of Coupled Folding and Binding of the Intrinsically Disordered Protein p53 with MDM2

Anchoring Intrinsically Disordered Proteins To Multiple Targets: Lessons From N-Terminus Of The P53 Protein

A computational analysis of interaction mechanisms of peptide and non-peptide inhibitors with MDMX based on molecular dynamics simulation

Smoothing molecular interactions: The “kinetic buffer” effect of intrinsically disordered proteins

Role of non-native electrostatic interactions in the coupled folding and binding of PUMA with Mcl-1

The Intrinsic Folding Mechanism Affects the Coupled Folding-Binding Process of Unfolded Proteins

Kinetic Advantage of Intrinsically Disordered Proteins in Coupled Folding–Binding Process: A Critical Assessment of the “Fly-Casting” Mechanism

Multi-Scaled Explorations of Binding-Induced Folding of Intrinsically Disordered Protein Inhibitor IA3 to Its Target Enzyme

Deciphering the Mystery in p300 Taz2-p53 TAD2 Recognition

The Dynamic Multisite Interactions Between Two Intrinsically Disordered Proteins

Global Conformational Selection and Local Induced Fit for the Recognition Between Intrinsic Disordered P53 and CBP.

Exploring the Binding Mechanism Between Human Profilin (PFN1) and Polyproline-10 Through Binding Mode Screening

Molecular Modeling and Molecular Dynamics Simulation Studies on Pyrrolopyrimidine-Based Α-Helix Mimetic As Dual Inhibitors of MDM2 and MDMX

Insight into Interaction Mechanism of the Inhibitor Pdi6w with MDM2 Based on Molecular Dynamics

Reconciling ASPP-p53 binding mode discrepancies through an ensemble binding framework that bridges crystallography and NMR data

Transient Protein States in Designing Inhibitors of the MDM2-p53 Interaction

Interplay Between Binding Affinity and Kinetics in Protein–protein Interactions

Insights into the Interaction Mechanisms of Peptide and Non-Peptide Inhibitors with MDM2 Using Gaussian-Accelerated Molecular Dynamics Simulations and Deep Learning

Deciphering the Multi-state Conformational Equilibrium of HDM2 in the Regulation of p53 Binding: Perspectives from Molecular Dynamics Simulation and NMR Analysis

Insight Into Binding Modes Of P53 And Inhibitors To Mdm2 Based On Molecular Dynamic Simulations And Principal Component Analysis